Skip to Content
Merck
  • An improved, high-efficiency assay for assessing serum anticholinergic activity using cultured cells stably expressing M1 receptors.

An improved, high-efficiency assay for assessing serum anticholinergic activity using cultured cells stably expressing M1 receptors.

Journal of pharmacological and toxicological methods (2017-03-10)
José N Nobrega, Roger J Raymond, Bruce G Pollock
ABSTRACT

Assessments of total anticholinergic activity (SAA) in serum are of considerable interest for its potential involvement in cognitive impairment associated with polydrug states in the elderly and other populations. Such estimations have been based on the displacement of radioligand binding in rat brain tissues. The validity of such measurements has been questioned, as a potentially distorting effect of large serum proteins was identified. We sought to develop a modified assay that would be more efficient and free of this potential confound. Cultured CHO cells stably expressing M1 receptors M1WT3 were used. Binding of

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
(±)-Quinuclidinyl benzilate, powder